Overview

Langerhans' cell histiocytosis in children is not very common, so community doctors usually have limited knowledge of the disease. This is why almost all children with Langerhans' cell histiocytosis in the United States receive treatment at one of the children’s cancer centers that make up the Children’s Oncology Group. Children and teens diagnosed with Langerhans' cell histiocytosis are treated at SCCA's parent organization, Seattle Children's, a member of COG.

Children’s blood disorders program brings together experts from more than 20 subspecialties to provide diagnostic services and treatments, including the very latest options. The team of pediatric hematologists, nurse practitioners, physician assistants, nurses, child life specialists, and chaplains partner with you to provide expert, family-centered care and compassionate support. We help you understand your child’s health and treatment options because you, your child and your family are an important part of the care team.

Because Children’s doctors take part in national and international research studies, and often lead them, Children’s can offer new treatment options that many other hospitals cannot give their patients.

Read more about Langerhans’ Cell Histiocytosis on the Seattle Children’s web site.

To make an appointment, call Seattle Children's at (206) 977-2106.